Edit |   |
---|---|
Antigenic Specificity | CD2, Human (Siplizumab biosimilar) |
Clone | Siplizumab |
Host Species | Recombinant Rat |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD2 Recombinant Antibody. Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease. |
Immunogen | n/a |
Other Names | Anti-CD2 Recombinant Antibody, Research Grade Siplizumab, Anti-Human CD2 Recombinant Antibody, MEDI-507, Antibody Drug Analogues, Monoclonal Antibody, YR1030, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 288392-69-8 |
Catalog # | YR1030 |
Price | please inquire |
Order / More Info | CD2, Human (Siplizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |